Home / Resource Library / Outcomes and treatment strategies following CD20/CD3 bispecific antibody failure in non-Hodgkins lymphoma: A retrospective single-center study
Outcomes and treatment strategies following CD20/CD3 bispecific antibody failure in non-Hodgkins lymphoma: A retrospective single-center study